Niacinamide 4% / Tazarotene 0.1%
Product Images NDC 72934-1161

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Niacinamide 4% / Tazarotene 0.1% (NDC 72934-1161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

W (2 End)

Side view of a white cylindrical container label for NIACINAMIDE 4% / TAZAROTENE 0.1% by Sincerus Florida, LLC. The label displays directions for use, including storage instructions and contact information for reporting adverse reactions. A QR code is also visible at the bottom of the label.*

FDA Label Image

F (1161 2 Front)

NIACINAMIDE USP 4% / TAZAROTENE 0.1% gel in a 30 gram white cylindrical container. The label shows the NDC number 72934-1161-2 and features a colored logo with the text Sincerus Florida. The product is identified as a compounded drug made in the USA.*

FDA Label Image

X (1161 2 Middle)

Partial view of a white plastic container with a label showing the active ingredients for NIACINAMIDE 4% / TAZAROTENE 0.1% topical gel. The label lists niacinamide USP 4% and tazarotene 0.1% as active ingredients, and suspension gel as an inactive ingredient. It also includes Rx only designation, lot number, and manufacturing and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.